Back to Directory Cindy Vavro Email cindy.l.vavro@viivhealthcare.com Phone 919 - 483-9184 Institution ViiV Healthcare Address ViiV Healthcare 5 Moore Drive RTP, NC 27709-3398 USA Request an Update Affiliated Studies P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed IMPAACT 2029: Phase I/II Study of Switching to Fixed Dose Combination Dolutegravir/Rilpivirine among Virologically Suppressed Children and Adolescents Living with HIV DAIDS Number 38717 Research Area Treatment Study Status Withdrawn
P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
IMPAACT 2029: Phase I/II Study of Switching to Fixed Dose Combination Dolutegravir/Rilpivirine among Virologically Suppressed Children and Adolescents Living with HIV DAIDS Number 38717 Research Area Treatment Study Status Withdrawn